What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Bacteria
David A. Stoltz spends much of his time researching Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Immunology, Lung and Respiratory system.
His Cystic fibrosis study incorporates themes from Inflammation, Endocrinology, Pancreatic disease and Pathogenesis.
His Cystic fibrosis transmembrane conductance regulator research incorporates elements of Mutation, Molecular biology and Pathology.
His Pathology study combines topics in areas such as Exocrine gland and Mucociliary clearance.
His Immunology research is multidisciplinary, incorporating perspectives in Andrology, Airway and In vivo.
His study in Respiratory system is interdisciplinary in nature, drawing from both Secretion, Mucin and Polysaccharide.
His most cited work include:
- Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. (610 citations)
- Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung (539 citations)
- Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth (385 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Pathology, Lung and Airway.
His studies deal with areas such as Inflammation, Immunology, Pathogenesis and Molecular biology as well as Cystic fibrosis.
His Immunology research is multidisciplinary, relying on both Microbiology and Bacteria.
Cystic fibrosis transmembrane conductance regulator is often connected to Mutation in his work.
His Lung study also includes
- Respiratory system and related Submucosal glands,
- In vivo that intertwine with fields like In vitro.
The study incorporates disciplines such as Lung volumes, Anatomy and Cell biology in addition to Airway.
He most often published in these fields:
- Cystic fibrosis (68.70%)
- Cystic fibrosis transmembrane conductance regulator (38.17%)
- Pathology (38.17%)
What were the highlights of his more recent work (between 2018-2021)?
- Cystic fibrosis (68.70%)
- Airway (33.59%)
- Lung (35.88%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cystic fibrosis, Airway, Lung, Submucosal glands and Respiratory system.
His Cystic fibrosis study is concerned with Internal medicine in general.
In his research, Cell type is intimately related to Cell biology, which falls under the overarching field of Airway.
His biological study spans a wide range of topics, including Contraction, Muscle contraction, Anatomy, Microscopy and Cystic fibrosis transmembrane conductance regulator.
David A. Stoltz interconnects Cell, In vitro and Gene expression in the investigation of issues within Cystic fibrosis transmembrane conductance regulator.
His Submucosal glands research includes themes of Ex vivo, In vivo and Host.
Between 2018 and 2021, his most popular works were:
- Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions. (24 citations)
- A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs. (14 citations)
- Mucus strands from submucosal glands initiate mucociliary transport of large particles (14 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Genetics
David A. Stoltz mainly focuses on Cystic fibrosis, Respiratory system, Submucosal glands, In vivo and Ex vivo.
He conducts interdisciplinary study in the fields of Cystic fibrosis and Persistence through his research.
His research integrates issues of Secretion, Gland secretion, Biophysics, Methacholine and Lung in his study of Respiratory system.
Submucosal glands is a subfield of Airway that he studies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
